ABAlexey Yu. Brazhnikov

Alexey Yu. Brazhnikov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexey Yu. Brazhnikov has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiological Characteristics of Acute Rheumatic Fever and Chronic Rheumatic Heart Disease in the Russian Federation and Moscow, 2012–2024

    by N. V. Nikitin, E. V. Glushkova, A. Y. Brazhnikov, A. O. Sukhareva, E. A. Sakharova, N. I. Briko

    Relevance. Acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) remain important medical and social problems despite a declining prevalence in most developed countries. These conditions are late complications of group A streptococcal infection and are associated with chronic valvular heart disease, disability, and premature mortality. Current evidence indicates persistent regional disparities in disease distribution and possible underestimation of the true disease burden. Aim . To assess long-term trends in the incidence, prevalence, and mortality of ARF and CRHD in the Russian Federation and Moscow during 2012–2024 and to evaluate age-specific and territorial characteristics of disease distribution. Materials and Methods . A retrospective descriptive epidemiological study was conducted. Data were obtained from Federal Statistical Reporting Forms No. 12 and No. 14. Analyses were performed for the total population and for the following age groups: children aged 0–14 years, adolescents aged 15–17 years, adults aged ≥ 18 years, working-age population, and older-than-working-age population. Incidence, prevalence, and mortality rates per 100,000 population, average long-term rates (ALR), average annual growth rates (AAGR), and trend significance coefficients (t) were calculated. Time-series analysis was performed using the least-squares method with trend-line construction. Results. A total of 24,815 cases of acute rheumatic fever (ARF) and 110,255 newly diagnosed cases of chronic rheumatic heart disease (CRHD) were registered in the Russian Federation between 2012 and 2024. A statistically significant decline in the main epidemiological indicators was observed. The incidence of ARF decreased 4.3-fold, from 1.76 to 0.41 per 100,000 population (AAGR = -9.6 %; p < 0.001). The incidence of CRHD decreased 1.8-fold, from 7.31 to 4.09 per 100,000 population (AAGR = -6.2 %; p < 0.001), while the prevalence of CRHD decreased 2.0-fold, from 130.88 to 66.06 per 100,000 population (AAGR = -5.8 %; p < 0.001). Mortality from ARF decreased 9.7-fold, from 0.03 to 0.003 per 100,000 population, whereas mortality from CRHD decreased 1.8-fold, from 1.09 to 0.60 per 100,000 population. The highest ARF incidence (ALR = 5.06 per 100,000 population), CRHD incidence (ALR = 13.67 per 100,000 population), and CRHD prevalence (ALR = 194.68 per 100,000 population) were observed in the North Caucasian Federal District. The highest ARF incidence was recorded among adolescents aged 15–17 years (ALR = 3.62 per 100,000 population), whereas CRHD predominantly affected individuals older than working age, with average long-term incidence and prevalence rates of 8.27 and 210.53 per 100,000 population, respectively. In Moscow, the main epidemiological indicators of ARF and CRHD were lower than the national averages and also demonstrated statistically significant declines over the study period. Conclusion . A decrease in the incidence, prevalence, and mortality associated with ARF and CRHD was observed in the Russian Federation and Moscow during 2012–2024. However, pronounced territorial disparities and age-related differences in disease distribution persist. These findings highlight the need for further improvement of epidemiological surveillance, prevention of group A streptococcal infection and its complications, and early detection of post-streptococcal diseases.


  • Open Access

    Long-term dynamics and age structure of the incidence of Shigella sonnei and Shigella flexneri infections in the Russian Federation, 2009–2024

    by A. Yu. Brazhnikov, M. O. Antipov, V. I. Mitkin, G. V. Panov

    Aim. To analyze long-term trends and age-specific patterns of S. sonnei and S. flexneri incidence in the Russian Federation over the period 2009–2024. Materials and methods . A retrospective analysis was conducted using data from the federal statistical surveillance (Form No. 2 «Information on infectious and parasitic diseases») for 2009–2024. Incidence rates were calculated per 100,000 population. Average annual incidence rates (AAIR) were computed as arithmetic means of annual values. The average annual rate of decline (increase) in incidence (AAR) was estimated from the linear regression coefficient to assess long-term trends. Statistical significance of differences was evaluated using Student's t-test, and confidence intervals were calculated by the Wald method. Results . The incidence of both shigellosis forms continued to decline, but the pace slowed down: for S. flexneri , AAR changed from -25.8 % (2003–2009) to -12.6 % (2009–2024); for S. sonnei , from -17.4 % to -11.6 %. Since 2022, the incidence of S. sonnei has for the first time significantly exceeded that of S. flexneri (previously S. flexneri had dominated for many years). Over the study period, the epidemic process of S. flexneri was characterized by a lack of pronounced cyclicity and a persistent shift of the highest incidence towards the youngest age groups (children under 1 year and 1–2 years; AAIR 14.11 and 17.69, respectively), indicating a predominantly contact-household transmission route. In contrast, S. sonnei showed regular periodic rises every 2–4 years, with peak incidence in children aged 3–6 years (AAIR 10.38); the proportion of cases among children aged 7–14 years was high (22.1 %). Discussion. The identified shift in the ratio of pathogens (predominance of S. sonnei since 2022) is consistent with international data and may be considered a marker of improved sanitary and hygienic conditions. The decline in incidence in 2020–2021 is attributed to anti-epidemic measures implemented during the COVID-19 pandemic. The parallel dynamics of S. flexneri incidence among children under 2 years of age and adults indirectly indicates a predominantly familial (contact-household) mode of transmission under current conditions of centralized water supply, whereas the distinct dynamics observed among children aged 3–6 and 7–14 years point to the role of organized groups in the spread of S. sonnei. Conclusion . Divergent changes were identified in the age structure and incidence ratio of S. sonnei and S. flexneri shigellosis, particularly pronounced in the post-pandemic period (since 2022).

  • Non-glaucomatous optic nerve atrophy: epidemiology, etiological structure, and clinical diagnostic features

    by N.L. Sheremet, N.M. Rustamova, A.A. Shaposhnikova, A.YU. Brazhnikov, N.I. Briko

    Non-glaucomatous optic nerve atrophy (ONA) is a polyetiological pathological condition characterized by the loss of retinal ganglion cell axons and structural changes in the optic nerve head. ONA is one of the leading causes of irreversible visual impairment and disability across different age groups. This review presents current data on the epidemiology, clinical and demographic characteristics, pathogenesis, classification, diagnosis, treatment, and prognosis of ONA.

  • Open Access

    Impact of MAFLD on quality of life and neuropsychological status in post-COVID patients: a cross-sectional analysis

    by Taisiia A. Turankova, Eva A. Verdiyan, Marina V. Novikova, Alexey Iu. Brazhnikov, Chavdar S. Pavlov

    Background. With the increasing prevalence of metabolic-associated fatty liver disease (MAFLD) among patients with metabolic syndrome, there is a growing incidence of neurocognitive decline, depression, and anxiety. Similar complaints are observed in post-COVID syndrome. This spectrum of disorders poses a significant socio-economic burden, substantially impacting quality of life and work capacity. Aim. To assess the quality of life, psycho-emotional, and cognitive status of patients with MAFLD who recovered from COVID-19-associated pneumonia (COVID-AP). Materials and methods. In a cross-sectional study utilizing telephone surveys, patients hospitalized for COVID-AP between December 2021 and January 2022 were evaluated for the need for subsequent hospitalization and any medical consultations after discharge; work capacity; memory impairments; stress levels; and quality of life using validated assessment scales. Results. A total of 71 patients were included in the final analysis: 17 patients with confirmed MAFLD and 54 controls. The groups were comparable by sex (p=0.55) and age (p=0.935). The MAFLD group demonstrated a higher frequency of impaired glucose tolerance (p0.001) and a need for medication and/or dietary interventions to control blood sugar following COVID-AP (odds ratio – OR 6.22; p=0.015). Patients with MAFLD showed reduced quality of life due to difficulties in daily activities (OR 17.967; p0.001), increased levels of anxiety and depression (OR 3.491; p=0.031), decreased health satisfaction (p=0.014); issues related to forgetfulness and memory (p=0.036), and short-term memory (p=0.013). MAFLD patients more frequently reported doubts about their ability to cope with personal problems (p=0.004) and dissatisfaction with their work capacity (p0.001). Conclusion. MAFLD significantly impairs quality of life, increases the risk of psychological stress and depression, worsens memory and cognitive functions, and reduces work capacity. Integrated clinical approaches addressing both metabolic and post-COVID complications are necessary to improve overall patient outcomes.

  • Primary incidence of cardiovascular diseases worldwide and in the Russian Federation from 1990 to 2021

    by Алексей Юрьевич Бражников, Виктория Михайловна Кураева, Olga Sh. Oynotkinova, Димитрий Павлович Дербенев, Ольга Шонкоровна Ойноткинова

    Introduction. Cardiovascular diseases (CVD) continue to lead among all causes of death in the world. The CVD incidence in countries continues to rise, despite existing containment strategies applied at various levels, including individual and country-based.The purpose of the study. To analyze the CVD incidence in populations across the world from 1990 to 2021.Materials and methods. Data were sourced from the online publication “Our World in Data.” Countries were grouped by disease incidence level using quartile division; hierarchical cluster analysis was performed via the average linkage method, and the average annual growth/decline rate (AR) of disease incidence was calculated.Results. The CVD incidence in the world from 1990 to 2021 decreased from 0.9 to 0.8 cases per 100 people (AR = –0.46%). In terms of the primary incidence of CVD in 2021, the Russian Federation is in the fourth quarter, in the group of countries with high incidence. Clustering showed the Russian Federation to be grouped with Algeria, Jordan and Mongolia, having similar incidence rates (1.28–1.29 cases per 100 people) and a tendency to decrease the incidence.Research limitations. For the analysis, age-standardized indices of CVD incidence from 204 countries for the period from 1990 to 2021 were used, constituting a highly representative sample.Conclusion. From 1990 to 2021, the global CVD incidence declined. As of 2021, the Russian Federation continued to be among the countries with the highest levels of CVD incidence, but at the same time, there was a downward trend in the incidence, which coincided with the trend in most countries of the world. Further research is needed to study the factors determining the revealed variability in the incidence and evaluate the effectiveness of measures aimed at reducing morbidity.Compliance with ethical standards. This type of research does not require an examination by the local ethics committee.Contribution of the authors: Brazhnikov A.Yu. — scientific guidance, concept and design of the research, formulation and development of material, statistical processing of data; Kuraeva V.M. — collection and processing of material, writing the text, editing, compiling the list of references; Oynotkinova O.Sh. — material processing, text writing, editing; Derbenev D.P. — material processing, text writing, editing. All authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.Funding. This article was prepared by the author’s team within the framework of the research “Innovative approaches in the development of the public health system of the city of Moscow” (No. according to EGISU: № 123032100060-2).Conflict of interest. The authors declare that there is no conflict of interest.Received: April 4, 2025 / Accepted: June 24, 2025 / Published: October 31, 2025

  • Assessment of students’ use of the internet in normal learning environments, during self-isolation during COVID-19 and after the pandemic

    by Владислав Ремирович Кучма, Natalia L. Yamshchikova, Анна Юрьевна Макарова, Алексей Юрьевич Бражников, Евгения Дмитриевна Лапонова, Елена Вячеславовна Нарышкина, Vladimir V. Chubarovsky, Надежда Николаевна Демина, Maria A. Leshcheva, Наталия Львовна Ямщикова, et al.

    Introduction. Since the Internet has made fundamental changes in work, social life, leisure, and communication, it has caused both optimism and concern. It is difficult for some people to limit its use, which adversely affects their lives, especially when it comes to children, adolescents, and young people. This has sparked a wide range of research ranging from psychology, sociology, and neuroscience. Several terms have been used to describe the problem, including Internet addiction, gaming disorder, and problematic Internet use. The COVID-19 pandemic that broke out in 2019 significantly affected the quality of life and led to Internet abuse. The lifting of quarantine allowed returning to the usual rhythm of life and, accordingly, the use of the Internet for study and work, as it was before self-isolation. The purpose of the study. To compare the use of the Internet before, on time, and after COVID-19 in medical university students.Materials and methods. The study asked students to rate their feelings and behaviors regarding internet use over the past six months. The “Problematic and Risky Internet Use Survey” (PRIUSS) was administered in both paper and Google Query formats. Participants in the first survey included two hundred thirty students; a year later, during the self-isolation period, 90 students participated; and two years later, 344 students participated.Results. The first survey found that 25.2% of respondents reported risks associated with internet use. In the second survey, the proportion of respondents with problems increased to 93.3%, and in the third survey, 20.9% of students experienced problems.Limitations. The sample of students studying at Medical universities in Moscow limits the possibility of generalizing the results to other regions and types of educational institutions.Conclusion. Problematic internet use increased sharply during the lockdown and returned to baseline levels two years after the pandemic. These findings suggest that problematic internet use and addiction prevention should be an important focus for reducing the risk of health-threatening behavior in children and young people.Compliance with ethical standards. Compliance with ethical standards. The study was conducted in accordance with the ethical standards set forth in the World Medical Association Declaration of Helsinki (8/19EC). All participants gave informed voluntary written consent to participate in the study.Contribution: Kuchma V.R. – concept, editing the article, approval of the final version of the article, responsibility for the integrity of all parts of the article; Yamshchikova N.L., Naryshkina E.V. – study concept and design, data collection, data processing, writing the text; Makarova A.Yu. – study concept and design, data collection, data processing; Brazhnikov A.Yu. – study concept and design, data processing, writing the text; Laponova E.D., Chubarovsky V.V. – study concept and design; Leshcheva M.A. – data processing; Demina N.N. – data collection, data processing.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: June 3, 2025 / Accepted: September 19, 2025 / Published: October 20, 2025

  • Open Access

    The effect of metabolic dysfunction-associated steatotic liver disease on the disease progression in patients with COVID-19 associated pneumonia

    by Taisiia Turankova, Philipp Roshchin, Dina Baimukhambetova, Oleg Mestnikov, Nadezhda Moroz, Daria Varganova, Marianna Semenistaia, Alexey Brazhnikov, Chavdar Pavlov

    Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common form of chronic liver disease, found in more than a quarter of the world’s population. People with MASLD are at a high risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The risk of a mild cold turning into severe pneumonia is also high. The aim of our study was to evaluate the effect of MASLD as a risk factor for the severity of coronavirus disease-associated pneumonia (COVID-AP). Methods: Our prospective, Russian cohort study included 100 adults (≥18 years old), of any sex, with COVID-AP. The SARS-CoV-2 infection was confirmed on nucleic acid amplification or using the SARS-CoV-2 antigen tests. Any possible secondary causes of liver steatosis were excluded, and alcohol consumption was assessed. The presence of significant hepatic steatosis (more than 30%) was estimated from computed tomography (CT) results. Results: Based on the presence of significant steatosis, in combination with other metabolic factors, two groups were formed: 25 patients with MASLD and 74 patients without significant steatosis, serving as controls. One patient was excluded from the MASLD group due to alcohol abuse. The two groups were comparable by sex (P=0.58) and age (P=0.96). Body mass index (BMI) (PConclusions: Liver steatosis, regardless of other metabolic risk factors, increased the need for biological therapy, whereas the need for antibiotic therapy was a consequence of T2DM. Our study showed a more severe course of COVID-AP in people with MASLD and higher mortality.

  • Open Access

    The introduction into clinical practice of an algorithm for the diagnosis of liver steatosis in patients with viral pneumonia

    by Taisia A. Turankova, Alexey Yu. Brazhnikov, Nadezhda G. Moroz, Anastasia V. Mudrova, Daria L. Varganova, Chavdar S. Pavlov

    Aim. To study the ability and significance of detecting liver steatosis during chest computed tomography (CT) in patients with viral pneumonia. Materials and methods. A prospective cohort study included 100 patients over the age of 18 who were hospitalized with an established diagnosis of viral pneumonia. To CT detection significant liver steatosis (more than 33%), several approaches were used: liver density less than 40 HU; decrease in liver density by at least 10 HU less than the spleen; the ratio of decrease in liver density to the spleen is less than 0.9. Results. According to CT data 2 groups were identified: 25 patients with existing liver steatosis and metabolically associated fatty liver disease, and 74 patients of the control group without signs of significant steatosis, оne patient was excluded due to alcohol abuse. There was a significant difference in the study of liver density (31.68 ± 10.67 and 54.44 ± 5.95; p 0.001), the ratio of decrease in liver density to spleen density (0.66 ± 0.22 and 1.16 ± 0.13; p 0.001), as well as a decrease in liver density relative to the spleen (16.30 ± 10.38 and -7.26 ± 6.10; p 0.001). In the steatosis group, a more severe course of pneumonia was noted (p = 0.041). The incidence of deterioration according to CT was comparable in both groups: 19 (76%) and 45 (60.8%); p = 0.169, although its severity was higher in the group with steatosis (p = 0.012). Patients from the steatosis group were significantly more often prescribed biological (88.0 and 39.19%; p 0.001) and antibacterial therapy (68.0 and 40.54%; p = 0.017). Conclusion. The use of assessment of liver steatosis according to CT data simultaneously with the study of the underlying disease can become an important diagnostic step determining the prognosis of the course of the disease, as well as a tool for risk stratification in patients with metabolically associated fatty liver disease.


  • Open Access

    Current State And Trends In The Incidence Of Chronic Kidney Disease Among Adult Population And Opportunities For Its Prevention And Treatment In Moscow Healthcare Organizations

    by Олег Николаевич Котенко, Надежда Владимировна Васина, Алексей Юрьевич Бражников, Виктория Михайловна Кураева

    Introduction. Currently, the incidence of kidney diseases among adult population is growing. It is expected to become the fifth leading cause of death by 2040. Showing no symptoms at early stages, chronic kidney disease (CKD) is closely related to diabetes mellitus, hypertension, obesity and kidney dysfunction in older age, which requires long-term and expensive treatment. Organization structure and the strategy of medical care provided by Moscow nephrology service is aimed at implementing measures for risk prevention and active early detection of kidney disease, as well as informing general population and medical community about existing diagnostic methods, modern treatment options and schemes. The purpose of the study was to identify trends in CKD prevalence and incidence among able-bodied population in the context of Moscow nephrology service improvement. Materials and Methods. An analysis of disease prevalence and incidence among able-bodied population based on official statistics data of the Russian Research Institute of Health (RIH) of the Ministry of Health of the Russian Federation and the Centre of Medical Statistics of Moscow Healthcare Department was carried out; indicators of time series and average growth/decrease rates were calculated. In order to identify a long-term trend, least squares method was used. Incidence rates were expressed per 100,000 able-bodied population. Results. In 2022, the overall disease prevalence in Moscow was lower than for the country as a whole (31.3 and 74.2 cases per 100,000 population, respectively), while incidence of the able-bodied population in Moscow was lower than countrywide (2.9 and 11.5 cases per 100,000 population, respectively). The long-term dynamics of CRD prevalence and incidence was generally characterized by an upward trend. Thus, the average annual incidence in Moscow was 9.8% and 6.1%, while in the Russian Federation 7.2% and 5.4%, respectively. On average, 91.3% of able-bodied patients with CKD in Moscow are under follow-up monitoring for a year. The number of dispensary patients with CKD increased by 2.5 times in 2022 in comparison to 2013, from 11.7 to 29.5 per 100,000 population, respectively. Since 2016, patients with newly diagnosed CKD have been provided with 100% coverage of follow-up monitoring.

  • Organizing the large multiple-center clinical trials based on modern digital approaches during the pandemic of a novel coronavirus infection in Moscow

    by E.S. Kucheryavykh, Yu.N. Karpova, Ya.S. Panarina, A.V. Starshinin, E.A. Tsareva, A.S. Bezymyannyy, A.G. Komarov, I.A. Shtinova, O.G. Shpakova, E.A. Slutsky, et al.

    Objective. To assess the effectivenes of the technologies aimed at the accelerated organisation and improved quality of the Gam-Covid-Vac Vaccine clinical trial in the Moscow healthcare institutions. Material and methods. The organizational structure of the research support and its resource support were described and analyzed. The study investigated regulatory documents issued by the Moscow Healthcare Department, primary medical records in line with the study protocol uploaded to the Unified Medical Information and Analytical System (EMIAS), electronic diaries of study participants, training programs for research teams, and the organization of their training. Results. The clinical trial was conducted collectively by 30 organizations, including 21 medical institutions. More than 400 physicians, including 79 physicians of telemedicine center, 185 nurses and 163 clinical monitors were involved. Online learning enabled to quickly educate the needed amount of clinical investigators. The organization model of research centers’ activity along with the combination of face-to-face visits and remote patient monitoring allowed to recruit volunteers, to observe them according to the protocol and to ensure their safety. The collection of primary medical data was integrated into EMIAS. It helped to receive the traceable and reliable data about volunteers’ health status and to monitor adverse events. All laboratory tests were carried out using the equipment and the reagents of one manufacturer. Because the central laboratory unified all study methodologies in a short period of time (less than 24 hours), the study results were recorded in the EMIAS-integrated information system. The vaccine was — delivered within a continuous cold chain supply using multi-level monitoring of test product storage temperature. Conclusions. The algorithm for improving quality and accelerating the clinical trial process of the Gam-COVID-Vac vaccine was developed, implemented, and put into action, driven by the capacities of the Moscow healthcare system, the electronic primary health records, the telemedicine system, a highly equipped central clinical laboratory, the ability to engage any medical experts, and the coordination and cooperation system of institutions. Moscow healthcare organizations could serve as a platform for large-scale clinical trials.